Key facts
- Notable investors include Firstgate (South Korea).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for A&RP Science
- ·The full record, as it builds
Funding rounds
No funding rounds for A&RP Science are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About A&RP Science
Developer of an immune and oncology research platform designed to support advanced preclinical evaluation for drug discovery. The company's platform offers in vivo imaging models, immuno-oncology systems, humanized and disease-specific animal models, and PDX screening capabilities, enabling pharmaceutical and research teams to assess therapeutic efficacy, accelerate development, and advance candidates with greater precision.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2021
- Website
- anrpscience.com/
- Ownership
- Privately Held (backing)
A&RP Science doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in A&RP Science shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on A&RP Science in its N-PORT filings yet. We sweep new filings monthly.